TB-500-MAX-10
Thymosin Beta-4 (43aa)|10 mg × 10 Vials
TB-500-MAX-10 is an experimental research product identified on the packaging as Thymosin Beta-4 (43aa).
Each vial contains 10 mg, with 10 vials per kit, providing a total labeled quantity of 100 mg.
Designed for qualified laboratory and research applications, TB-500-MAX-10 provides researchers with a clearly identified peptide format suitable for controlled experimental workflows.
Product Highlights
About Thymosin Beta-4
Thymosin Beta-4 (Tβ4) is a naturally occurring peptide that has been investigated extensively in cellular and preclinical research.
The peptide has attracted scientific interest because of its association with several biological processes, including actin regulation, cellular migration, cytoskeletal dynamics, and tissue-related cellular responses.
Research involving Thymosin Beta-4 has examined its biological activity in different experimental models and has contributed to the broader study of peptide-mediated cellular mechanisms.
The product shown here is identified on the packaging as Thymosin Beta-4 (43aa). Researchers should consult the product's batch-specific analytical documentation to confirm molecular identity, sequence, purity, and other specifications.
Experimental and preclinical findings should not be interpreted as established evidence of safety or efficacy in humans.
Product Specifications
| PRODUCT NAME | TB-500-MAX-10 |
| COMPOUND | Thymosin Beta-4 (43aa) |
| COMMON RESEARCH NAME | TB-500 |
| QUANTITY PER VIAL | 10 mg |
| NUMBER OF VIALS | 10 |
| TOTAL QUANTITY | 100 mg |
| PRODUCT TYPE | Research Peptide |
| SEQUENCE | 43 amino acids, as stated on packaging |
| PHYSICAL FORM | Verify with manufacturer |
| INTENDED APPLICATION | Laboratory / Research Use |
| PACKAGING | 10-vial kit |
| BRAND | Maxtreme Pharma |
Note: The product image establishes the 10 mg vial strength, 10-vial configuration, 100 mg total quantity, and the "Thymosin Beta-4 (43aa)" designation. Purity, formulation, physical form, sequence details, and analytical specifications should be confirmed through the manufacturer's current technical documentation or CoA.
Research Applications
Thymosin Beta-4 has been investigated in experimental research involving a range of cellular and molecular processes. Research areas may include:
Researchers may investigate Thymosin Beta-4 in controlled experimental systems to better understand its biological activity and interaction with cellular pathways. These research areas describe experimental investigation only and do not constitute approved medical indications or recommendations for human use.
Thymosin Beta-4 Research Profile
Thymosin Beta-4 is a peptide associated with the regulation of actin dynamics and cellular processes. Its interaction with actin-related pathways has made it an important subject of experimental cellular biology research.
Laboratory and preclinical studies have investigated its relationship with processes such as cell migration, cytoskeletal organization, cellular signaling, and tissue-associated biological responses.
The scientific literature surrounding Thymosin Beta-4 includes experimental models investigating different biological mechanisms. However, results obtained from laboratory or animal models should not automatically be extrapolated to therapeutic outcomes in humans.
For research procurement, the precise identity and characteristics of the supplied material should be established through batch-specific analytical documentation.
Quality & Packaging
The TB-500-MAX-10 kit contains 10 individually packaged vials, with 10 mg of labeled peptide per vial, providing a total labeled quantity of 100 mg per kit.
The packaging identifies the product as TB-500-MAX-10 and describes the compound as Thymosin Beta-4 (43aa).
For professional research procurement, researchers should verify the applicable: Certificate of Analysis (CoA), batch/lot number, peptide identity, sequence information, purity specification, assay results, analytical testing, formulation information, and storage requirements.
For peptide research materials, batch-specific analytical documentation is particularly useful for confirming identity and quality characteristics.
Storage & Handling
Store and handle TB-500-MAX-10 according to the manufacturer's batch-specific technical documentation and Certificate of Analysis.
Peptide stability can be affected by factors including temperature, moisture, light exposure, formulation, and handling conditions.
Researchers should follow the manufacturer's documented storage and handling requirements rather than relying on generic storage recommendations. Appropriate laboratory procedures and applicable safety protocols should be followed when handling experimental peptide materials.
TB-500-MAX-10 is an experimental research peptide product identified on the packaging as Thymosin Beta-4 (43aa).
This product is not presented as a drug, dietary supplement, or approved treatment for any medical condition.
This product is intended only for qualified research and laboratory applications, subject to applicable laws, regulations, institutional requirements, and laboratory safety procedures.
No claim is made that this product or its constituent peptide is safe or effective for the diagnosis, treatment, cure, or prevention of any disease or medical condition.
Not for human consumption or self-administration.
Frequently Asked Questions
TB-500-MAX-10 is an experimental research peptide product identified on the packaging as Thymosin Beta-4 (43aa).
Each vial contains 10 mg according to the product packaging.
The kit contains 10 vials.
The kit contains 100 mg total, calculated as: 10 vials × 10 mg = 100 mg.
Thymosin Beta-4 (Tβ4) is a naturally occurring peptide that has been investigated in cellular, molecular, and preclinical research.
"43aa" refers to a peptide sequence consisting of 43 amino acids. The product packaging specifically identifies the material as Thymosin Beta-4 (43aa).
TB-500 is a name commonly used in research and commercial contexts for peptide products associated with Thymosin Beta-4. Because terminology can vary between products, researchers should verify the exact molecular identity, sequence, purity, and specifications through the manufacturer's documentation.
Thymosin Beta-4 has been investigated in experimental research involving cellular migration, actin dynamics, cytoskeletal biology, cell signaling, and tissue-related cellular processes. These research areas do not constitute approved medical applications.
This product should not be presented as an approved human therapeutic. It should be positioned as an experimental research product and marketed according to applicable regulatory requirements.
No. The product should be presented as For Research Use Only and not for human consumption or self-administration, subject to applicable laws and regulatory requirements.
Professional research customers should request the applicable Certificate of Analysis (CoA) and batch information, including peptide identity, sequence, purity, assay results, analytical testing, formulation, and storage requirements.